Peroxisome Proliferator-activated Receptor Gamma Activation Induces Cell Cycle Arrest via the p53-independent Pathway in Human Anaplastic Thyroid Cancer Cells-Reference-Cited by-同舟云学术

Peroxisome Proliferator-activated Receptor Gamma Activation Induces Cell Cycle Arrest via the p53-independent Pathway in Human Anaplastic Thyroid Cancer Cells

Published:2002-12 Issue:12 Volume:93 Page:1358-1365
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Chung Sung Hwa,Onoda Naoyoshi,Ishikawa Tetsuro,Ogisawa Kana,Takenaka Chiemi,Yano Yoshihisa,Hato Fumihiko,Hirakawa Kosei

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2002.tb01245.x/fullpdf

Reference37 articles.

1. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases;Nel;Mayo Clin. Proc.,1995

2. Anaplastic thyroid carcinoma: risk factors and outcome;Demeter;Surgery,1991

3. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 121 cases;Venkatesh;Cancer,1990

4. Peroxisome proliferator-activated receptor (PPAR) γ: adipose-predominant expression and induction early in adipocyte differentiation;Chawla;Endocrinology,1994

5. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor;Tontonz;Cell,1994

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs;Frontiers in Pharmacology;2023-12-11

2. Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas;Heliyon;2023-12

3. Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy;Scientific Reports;2023-11-24

4. Road crossings change functional diversity and trait composition of stream-dwelling macroinvertebrate assemblages;Scientific Reports;2023-11-24

5. Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells;Cancer Science;2022-07-12